NEW YORK (GenomeWeb News) — A network of 37 genomics research groups from 13 European countries has adopted an agenda for pathogenomics research that includes increasing emphasis on pathogen/host interaction and on using bioinformatics technologies, according to the alliance.
 
The Network of Excellence EuroPathoGenomics is a five-year, €6.7-million ($9 million) European Commission initiative begun in 2005. The group met in April to outline a new direction for its programs and to discuss the future of genomics research in Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.